Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.

Wheelock CE, Goss VM, Balgoma D, Nicholas B, Brandsma J, Skipp PJ, Snowden S, Burg D, D'Amico A, Horvath I, Chaiboonchoe A, Ahmed H, Ballereau S, Rossios C, Chung KF, Montuschi P, Fowler SJ, Adcock IM, Postle AD, Dahlén SE, Rowe A, Sterk PJ, Auffray C, Djukanovic R; U-BIOPRED Study Group..

Eur Respir J. 2013 Sep;42(3):802-25. doi: 10.1183/09031936.00078812. Review.

2.

Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.

Wolahan SM, Hirt D, Glenn TC.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25.

3.

Toward composite molecular signatures in the phenotyping of asthma.

Wagener AH, Yick CY, Brinkman P, van der Schee MP, Fens N, Sterk PJ.

Ann Am Thorac Soc. 2013 Dec;10 Suppl:S197-205. doi: 10.1513/AnnalsATS.201302-035AW. Review.

PMID:
24313773
4.

Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.

Zhao YY, Cheng XL, Lin RC.

Int Rev Cell Mol Biol. 2014;313:1-26. doi: 10.1016/B978-0-12-800177-6.00001-3. Review.

PMID:
25376488
5.

Mass spectrometry: from proteomics to metabolomics and lipidomics.

Griffiths WJ, Wang Y.

Chem Soc Rev. 2009 Jul;38(7):1882-96. doi: 10.1039/b618553n. Review.

PMID:
19551169
6.

Advances in proteomic techniques for biomarker discovery in COPD.

Casado B, Luisetti M, Iadarola P.

Expert Rev Clin Immunol. 2011 Jan;7(1):111-23. doi: 10.1586/eci.10.75.

PMID:
21162654
7.

On the future of "omics": lipidomics.

Griffiths WJ, Ogundare M, Williams CM, Wang Y.

J Inherit Metab Dis. 2011 Jun;34(3):583-92. doi: 10.1007/s10545-010-9274-4. Review.

PMID:
21318352
8.

UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.

Zhao YY, Lin RC.

Chem Biol Interact. 2014 May 25;215:7-16. doi: 10.1016/j.cbi.2014.02.014. Review.

PMID:
24631021
9.

A review on airway biomarkers: exposure, effect and susceptibility.

Corradi M, Goldoni M, Mutti A.

Expert Rev Respir Med. 2015 Apr;9(2):205-20. doi: 10.1586/17476348.2015.1001373. Review.

PMID:
25561087
10.

The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.

Badawi A.

Infect Dis Ther. 2016 Nov 29. [Epub ahead of print] Review.

PMID:
27900646
11.

Analytical strategies in lipidomics and applications in disease biomarker discovery.

Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Sep 15;877(26):2836-46. doi: 10.1016/j.jchromb.2009.01.038. Review.

PMID:
19233743
12.

Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.

Evans CR, Karnovsky A, Kovach MA, Standiford TJ, Burant CF, Stringer KA.

J Proteome Res. 2014 Feb 7;13(2):640-9. doi: 10.1021/pr4007624.

13.

Optimizing the lipidomics workflow for clinical studies--practical considerations.

Hyötyläinen T, Orešič M.

Anal Bioanal Chem. 2015 Jul;407(17):4973-93. doi: 10.1007/s00216-015-8633-2. Review.

PMID:
25855150
14.

Proteomic analysis of the asthmatic airway.

Wiktorowicz JE, Jamaluddin M.

Adv Exp Med Biol. 2014;795:221-32. doi: 10.1007/978-1-4614-8603-9_14. Review.

PMID:
24162912
15.

Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease.

Barallobre-Barreiro J, Chung YL, Mayr M.

Rev Esp Cardiol (Engl Ed). 2013 Aug;66(8):657-61. doi: 10.1016/j.rec.2013.04.009. Review.

PMID:
24776335
16.
17.

Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation.

Neujahr DC, Uppal K, Force SD, Fernandez F, Lawrence C, Pickens A, Bag R, Lockard C, Kirk AD, Tran V, Lee K, Jones DP, Park Y.

Am J Transplant. 2014 Apr;14(4):841-8. doi: 10.1111/ajt.12631.

18.

Lipidomics applications for disease biomarker discovery in mammal models.

Zhao YY, Cheng XL, Lin RC, Wei F.

Biomark Med. 2015;9(2):153-68. doi: 10.2217/bmm.14.81. Review.

PMID:
25689902
19.

Lipidomics from an analytical perspective.

Sandra K, Sandra P.

Curr Opin Chem Biol. 2013 Oct;17(5):847-53. doi: 10.1016/j.cbpa.2013.06.010. Review.

PMID:
23830914
20.

Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.

Chen Z, Kim J.

BMC Urol. 2016 Mar 22;16:11. doi: 10.1186/s12894-016-0129-7. Review.

Items per page

Supplemental Content

Support Center